Previous close | 4.1800 |
Open | 4.2200 |
Bid | 4.2300 x 300 |
Ask | 4.3000 x 100 |
Day's range | 4.1900 - 4.3800 |
52-week range | 4.1400 - 29.8800 |
Volume | |
Avg. volume | 1,251,013 |
Market cap | 420.38M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Quite a few insiders have dramatically grown their holdings in Acelyrin, Inc. ( NASDAQ:SLRN ) over the past 12 months...
The most well known IPOs so far this year that have made headlines and moved the markets.
The recently public biopharma company announced disappointing results from a clinical trial of its lead drug candidate.